Post-translational modification of NMDA receptor GluN2B subunit and its roles in chronic pain and memory

Seminars in Cell and Developmental Biology

Volumn 22, Issue 5, 2011, Pages 521-529

  Qiu, Shuang ^a   Li, Xiang Yao ^a   Zhuo, Min ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Seoul National University   (South Korea)

Author keywords

Chronic pain; GluN2B subunit; NMDA receptor; Post translational modification

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B;

CHRONIC PAIN; DEGENERATIVE DISEASE; HUMAN; ISCHEMIA; LEARNING; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MEMORY; PALMITOYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; UBIQUITINATION;

EID: 80053568271     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2011.06.003     Document Type: Review

References (64)

1. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
2. Cull-Candy S.G., Leszkiewicz D.N. Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004 2004, re16.
3. Zhuo M. Cortical excitation and chronic pain. Trends Neurosci 2008, 31:199-207.
4. Kandel E.R. The molecular biology of memory storage: a dialogue between genes and synapses. Science 2001, 294:1030-1038.
5. Zhuo M. Plasticity of NMDA receptor NR2B subunit in memory and chronic pain. Mol Brain 2009, 2:4.
6. Li X.Y., Ko H.G., Chen T., Descalzi G., Koga K., Wang H., et al. Alleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortex. Science 2010, 330:1400-1404.
7. Wu L.J., Toyoda H., Zhao M.G., Lee Y.S., Tang J., Ko S.W., et al. Upregulation of forebrain NMDA NR2B receptors contributes to behavioral sensitization after inflammation. J Neurosci 2005, 25:11107-11116.
8. Lau C.G., Zukin R.S. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 2007, 8:413-426.
9. Qiu S., Hua Y.L., Yang F., Chen Y.Z., Luo J.H. Subunit assembly of N-methyl-d-aspartate receptors analyzed by fluorescence resonance energy transfer. J Biol Chem 2005, 280:24923-24930.
10. Sobolevsky A.I., Yelshansky M.V., Wollmuth L.P. The outer pore of the glutamate receptor channel has 2-fold rotational symmetry. Neuron 2004, 41:367-378.
11. Furukawa H., Gouaux E. Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core. EMBO J 2003, 22:2873-2885.
12. Qiu S., Zhang X.M., Cao J.Y., Yang W., Yan Y.G., Shan L., et al. An endoplasmic reticulum retention signal located in the extracellular amino-terminal domain of the NR2A subunit of N-methyl-d-aspartate receptors. J Biol Chem 2009, 284:20285-20298.
13. Yang W., Zheng C., Song Q., Yang X., Qiu S., Liu C., et al. A three amino acid tail following the TM4 region of the N-methyl-d-aspartate receptor (NR) 2 subunits is sufficient to overcome endoplasmic reticulum retention of NR1-1a subunit. J Biol Chem 2007, 282:9269-9278.
14. Kim E., Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci 2004, 5:771-781.
15. Scott D.B., Michailidis I., Mu Y., Logothetis D., Ehlers M.D. Endocytosis and degradative sorting of NMDA receptors by conserved membrane-proximal signals. J Neurosci 2004, 24:7096-7109.
16. Ehlers M.D. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat Neurosci 2003, 6:231-242.
17. Liao G.Y., Wagner D.A., Hsu M.H., Leonard J.P. Evidence for direct protein kinase-C mediated modulation of N-methyl-d-aspartate receptor current. Mol Pharmacol 2001, 59:960-964.
18. Liu X.Y., Chu X.P., Mao L.M., Wang M., Lan H.X., Li M.H., et al. Modulation of D2R-NR2B interactions in response to cocaine. Neuron 2006, 52:897-909.
19. Tu W., Xu X., Peng L., Zhong X., Zhang W., Soundarapandian M.M., et al. DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 2010, 140:222-234.
20. Chung H.J., Huang Y.H., Lau L.F., Huganir R.L. Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B subunit PDZ ligand. J Neurosci 2004, 24:10248-10259.
21. Sanz-Clemente A., Matta J.A., Isaac J.T., Roche K.W. Casein kinase 2 regulates the NR2 subunit composition of synaptic NMDA receptors. Neuron 2010, 67:984-996.
22. Nakazawa T., Komai S., Tezuka T., Hisatsune C., Umemori H., Semba K., et al. Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-d-aspartate receptor. J Biol Chem 2001, 276:693-699.
23. Lavezzari G., McCallum J., Lee R., Roche K.W. Differential binding of the AP-2 adaptor complex and PSD-95 to the C-terminus of the NMDA receptor subunit NR2B regulates surface expression. Neuropharmacology 2003, 45:729-737.
24. Roche K.W., Huganir R.L. Detection of protein phosphorylation in tissues and cells. Current protocols in neuroscience 2001, vol. 14. (Chapter 5: Unit 5).
25. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., et al. Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 2005, 8:1051-1058.
26. Wu H.Y., Hsu F.C., Gleichman A.J., Baconguis I., Coulter D.A., Lynch D.R. Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpain-mediated NR2B cleavage in neurons and heterologous systems. J Biol Chem 2007, 282:20075-20087.
27. Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002, 82:373-428.
28. Colledge M., Snyder E.M., Crozier R.A., Soderling J.A., Jin Y., Langeberg L.K., et al. Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression. Neuron 2003, 40:595-607.
29. Jurd R., Thornton C., Wang J., Luong K., Phamluong K., Kharazia V., et al. Mind bomb-2 is an E3 ligase that ubiquitinates the N-methyl-d-aspartate receptor NR2B subunit in a phosphorylation-dependent manner. J Biol Chem 2008, 283:301-310.
30. Bijlmakers M.J., Marsh M. The on-off story of protein palmitoylation. Trends Cell Biol 2003, 13:32-42.
31. Hayashi T., Rumbaugh G., Huganir R.L. Differential regulation of AMPA receptor subunit trafficking by palmitoylation of two distinct sites. Neuron 2005, 47:709-723.
32. Ponimaskin E.G., Heine M., Joubert L., Sebben M., Bickmeyer U., Richter D.W., et al. The 5-hydroxytryptamine(4a) receptor is palmitoylated at two different sites, and acylation is critically involved in regulation of receptor constitutive activity. J Biol Chem 2002, 277:2534-2546.
33. 2+ channel beta subunit caused by palmitoylation. Proc Natl Acad Sci USA 1998, 95:4690-4695.
34. Fukata Y., Fukata M. Protein palmitoylation in neuronal development and synaptic plasticity. Nat Rev Neurosci 2010, 11:161-175.
35. Yang G., Xiong W., Kojic L., Cynader M.S. Subunit-selective palmitoylation regulates the intracellular trafficking of AMPA receptor. Eur J Neurosci 2009, 30:35-46.
36. Hayashi T., Thomas G.M., Huganir R.L. Dual palmitoylation of NR2 subunits regulates NMDA receptor trafficking. Neuron 2009, 64:213-226.
37. Zhao M.G., Toyoda H., Lee Y.S., Wu L.J., Ko S.W., Zhang X.H., et al. Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory. Neuron 2005, 47:859-872.
38. Miwa H., Fukaya M., Watabe A.M., Watanabe M., Manabe T. Functional contributions of synaptically localized NR2B subunits of the NMDA receptor to synaptic transmission and long-term potentiation in the adult mouse CNS. J Physiol 2008, 586:2539-2550.
39. Liu L., Wong T.P., Pozza M.F., Lingenhoehl K., Wang Y., Sheng M., et al. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 2004, 304:1021-1024.
40. Tang Y.P., Shimizu E., Dube G.R., Rampon C., Kerchner G.A., Zhuo M., et al. Genetic enhancement of learning and memory in mice. Nature 1999, 401:63-69.
41. Bauer E.P., Schafe G.E., LeDoux J.E. NMDA receptors and L-type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala. J Neurosci 2002, 22:5239-5249.
42. Berberich S., Jensen V., Hvalby O., Seeburg P.H., Kohr G. The role of NMDAR subtypes and charge transfer during hippocampal LTP induction. Neuropharmacology 2007, 52:77-86.
43. Zhang X.H., Liu F., Chen Q., Zhang C.L., Zhuo M., Xiong Z.Q., et al. Conditioning-strength dependent involvement of NMDA NR2B subtype receptor in the basolateral nucleus of amygdala in acquisition of auditory fear memory. Neuropharmacology 2008, 55:238-246.
44. Dudek S.M., Bear M.F. Homosynaptic long-term depression in area Ca1 of hippocampus and effects of N-methyl-d-aspartate receptor blockade. Proc Natl Acad Sci USA 1992, 89:4363-4367.
45. Feldman D.E., Knudsen E.I. Experience-dependent plasticity and the maturation of glutamatergic synapses. Neuron 1998, 20:1067-1071.
46. Toyoda H., Zhao M.G., Zhuo M. Roles of NMDA receptor NR2A and NR2B subtypes for long-term depression in the anterior cingulate cortex. Eur J Neurosci 2005, 22:485-494.
47. Zhang X.H., Wu L.J., Gong B., Ren M., Li B.M., Zhuo M. Induction- and conditioning-protocol dependent involvement of NR2B-containing NMDA receptors in synaptic potentiation and contextual fear memory in the hippocampal CA1 region of rats. Mol Brain 2008, 1:9.
48. Zinebi F., Xie J., Liu J., Russell R.T., Gallagher J.P., McKernan M.G., et al. NMDA currents and receptor protein are downregulated in the amygdala during maintenance of fear memory. J Neurosci 2003, 23:10283-10291.
49. Walker D.L., Davis M. Amygdala infusions of an NR2B-selective or an NR2A-preferring NMDA receptor antagonist differentially influence fear conditioning and expression in the fear-potentiated startle test. Learn Mem 2008, 15:67-74.
50. Matta J.A., Ashby M.C., Sanz-Clemente A., Roche K.W., Isaac J.T. mGluR5 and NMDA receptors drive the experience- and activity-dependent NMDA receptor NR2B to NR2A subunit switch. Neuron 2011, 70:339-351.
51. Wei F., Qiu C.S., Kim S.J., Muglia L., Maas J.W., Pineda V.V., et al. Genetic elimination of behavioral sensitization in mice lacking calmodulin-stimulated adenylyl cyclases. Neuron 2002, 36:713-726.
52. Wei F., Wang G.D., Kerchner G.A., Kim S.J., Xu H.M., Chen Z.F., et al. Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nat Neurosci 2001, 4:164-169.
53. Liauw J., Wu L.J., Zhuo M. Calcium-stimulated adenylyl cyclases required for long-term potentiation in the anterior cingulate cortex. J Neurophysiol 2005, 94:878-882.
54. Abe T., Matsumura S., Katano T., Mabuchi T., Takagi K., Xu L., et al. Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain. Eur J Neurosci 2005, 22:1445-1454.
55. Nakazawa T., Komai S., Watabe A.M., Kiyama Y., Fukaya M., Arima-Yoshida F., et al. NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticity. EMBO J 2006, 25:2867-2877.
56. Katano T., Nakazawa T., Nakatsuka T., Watanabe M., Yamamoto T., Ito S. Involvement of spinal phosphorylation cascade of Tyr1472-NR2B, Thr286-CaMKII, and Ser831-GluR1 in neuropathic pain. Neuropharmacology 2011, 60:609-616.
57. Jiang X., Mu D., Biran V., Faustino J., Chang S., Rincon C.M., et al. Activated Src kinases interact with the N-methyl-d-aspartate receptor after neonatal brain ischemia. Ann Neurol 2008, 63:632-641.
58. Cheung H.H., Teves L., Wallace M.C., Gurd J.W. Inhibition of protein kinase C reduces ischemia-induced tyrosine phosphorylation of the N-methyl-d-aspartate receptor. J Neurochem 2003, 86:1441-1449.
59. Dos-Anjos S., Martinez-Villayandre B., Montori S., Perez-Garcia C.C., Fernandez-Lopez A. Early modifications in N-methyl-d-aspartate receptor subunit mRNA levels in an oxygen and glucose deprivation model using rat hippocampal brain slices. Neuroscience 2009, 164:1119-1126.
60. Mishizen-Eberz A.J., Rissman R.A., Carter T.L., Ikonomovic M.D., Wolfe B.B., Armstrong D.M. Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology. Neurobiol Dis 2004, 15:80-92.
61. Sze C., Bi H., Kleinschmidt-DeMasters B.K., Filley C.M., Martin L.J. N-methyl-d-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease. J Neurol Sci 2001, 182:151-159.
62. Dunah A.W., Wang Y., Yasuda R.P., Kameyama K., Huganir R.L., Wolfe B.B., et al. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-d-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol Pharmacol 2000, 57:342-352.
63. Rogawski M.A., Wenk G.L. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. CNS Drug Rev 2003, 9:275-308.
64. Gardoni F., Picconi B., Ghiglieri V., Polli F., Bagetta V., Bernardi G., et al. A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J Neurosci 2006, 26:2914-2922.